3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
10
OTHER_GOV
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
2
Solid Tumors
1
Sarcoma
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Triple Negative Breast Cancer
1
Advanced Gastric Adenocarcinoma
1
Interventions
Cisplatin
3
sintilimab
2
toripalimab
1
camrelizumab
1
anlotinib
1
TP protocol
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
Nivolumab
1
Neoadjuvant Therapy
1
Immune Checkpoint Inhibitors
1
Fluorouracil
1
Docetaxel
1
Chemoradiotherapy
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Esophageal Squamous Cell Carcinoma
×
Albumin-Bound Paclitaxel
×
Clear all
NCT05007145
2021-12-21
REVO
Fujian Cancer Hospital
Phase 2
Unknown
92 enrolled